Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials

Archives of Cardiovascular Diseases

Volumn 105, Issue 4, 2012, Pages 226-238

  Caldeira, Daniel ^a   David, Cláudio ^a,b   Sampaio, Cristina ^a,c  

^a FACULDADE DE MEDICINA DENTÁRIA   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c Institute de Molecular Medicine   (Portugal)

Author keywords

Adrenergic beta antagonists; Antiarrhythmia agents; Atrial fibrillation; Calcium channel blockers; Digitalis

Indexed keywords

ACENOCOUMAROL; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIBENZOLINE; DIGITALIS; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; PHENPROCOUMON; PILSICAINIDE; PROPAFENONE; SOTALOL;

ANTICOAGULATION; BLEEDING; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERY DISEASE; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; EMBOLISM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PALPITATION; HEART RATE; HEART RHYTHM; HUMAN; HYPERTENSION; META ANALYSIS; OUTCOME ASSESSMENT; PACEMAKER; PATIENT PREFERENCE; RECURRENT DISEASE; REVIEW; SUDDEN DEATH; SYSTEMATIC REVIEW; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; EVIDENCE-BASED MEDICINE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84861581320     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.11.005     Document Type: Review

References (36)

1. E.J. Benjamin, D. Levy, and S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study JAMA 271 1994 840 844
2. D.M. Lloyd-Jones, T.J. Wang, and E.P. Leip Lifetime risk for development of atrial fibrillation: the Framingham heart study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
4. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham heart study Circulation 98 1998 946 952 (Pubitemid 28446646)
5. R.L. Page Clinical practice. Newly diagnosed atrial fibrillation N Engl J Med 351 2004 2408 2416
6. S.J. Saxonhouse, and A.B. Curtis Risks and benefits of rate control versus maintenance of sinus rhythm Am J Cardiol 91 2003 27D 32D (Pubitemid 36369331)
7. V.H. Deneer, M.B. Borgh, and J.H. Kingma Oral antiarrhythmic drugs in converting recent onset atrial fibrillation Pharm World Sci 26 2004 66 78 (Pubitemid 38425436)
8. T.J. Wang, J.M. Massaro, and D. Levy A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham heart study JAMA 290 2003 1049 1056 (Pubitemid 37430445)
9. C.G. Maher, C. Sherrington, and R.D. Herbert Reliability of the PEDro scale for rating quality of randomized controlled trials Phys Ther 83 2003 713 721 (Pubitemid 37238882)
10. J. Carlsson, S. Miketic, and J. Windeler Randomized trial of rate control versus rhythm ontrol in persistent atrial fibrillation: the strategies of treatment of atrial fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696 (Pubitemid 36584236)
11. S.H. Hohnloser, K.H. Kuck, and J. Lilienthal Rhythm or rate control in atrial fibrillation - pharmacological intervention in atrial fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
12. S. Ogawa, T. Yamashita, and T. Yamazaki Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study Circ J 73 2009 242 248
13. G. Opolski, A. Torbicki, and D.A. Kosior Rate control vs rhythm control in patients with non-valvular persistent atrial fibrillation: the results of the polish how to treat chronic atrial fibrillation (HOT CAFE) study Chest 126 2004 476 486 (Pubitemid 39093433)
14. D. Roy, M. Talajic, and S. Nattel Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
15. R.J. Shelton, A.L. Clark, and K. Goode A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study) Heart 95 2009 924 930
16. I.C. Van Gelder, V.E. Hagens, and H.A. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840 (Pubitemid 35417774)
17. D.G. Wyse, A.L. Waldo, and J.P. DiMarco A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
18. V.E. Hagens, M. Rienstra, and D.J. Van Veldhuisen Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study Am J Cardiol 98 2006 929 932 (Pubitemid 44402267)
19. J.S. Steinberg, A. Sadaniantz, and J. Kron Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Circulation 109 2004 1973 1980 (Pubitemid 38552376)
20. Sterne JAC, Egger M, Moher D. (editors). Chapter 10: Addressing reporting biases. Cochrane Handbook for Systematic Reviews of Intervention. Version 5.0.1 (updated September 2008): The Cochrane Collaboration; 2008. Available at: http://www.mrc-bsu.cam.ac.uk/cochrane/handbook/chapter-10/10-addressing- reporting-biases.htm.
21. S. de Denus, C.A. Sanoski, and J. Carlsson Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Arch Intern Med 165 2005 258 262 (Pubitemid 40216276)
22. L. Testa, G.G. Biondi-Zoccai, and A. Dello Russo Rate control vs. rhythm control in patients with atrial fibrillation: a meta-analysis Eur Heart J 26 2005 2000 2006 (Pubitemid 41439642)
23. W.A. Wattigney, G.A. Mensah, and J.B. Croft Increased atrial fibrillation mortality: United States, 1980-1998 Am J Epidemiol 155 2002 819 826 (Pubitemid 34456992)
24. P.H. Held, and S. Yusuf Effects of beta-blockers and calcium-channel blockers in acute myocardial infarction Eur Heart J 14 Suppl. F 1993 18 25 (Pubitemid 23307528)
25. J.A. Joglar, A.P. Acusta, and N.H. Shusterman Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program Am Heart J 142 2001 498 501 (Pubitemid 32801635)
26. D.S. Echt, P.R. Liebson, and L.B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
27. A.E. Buxton, K.L. Lee, and J.D. Fisher A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators N Engl J Med 341 1999 1882 1890
28. S.R. Kahn, S. Solymoss, and K.M. Flegel Non-valvular atrial fibrillation: evidence for a prothrombotic state CMAJ 157 1997 673 681 (Pubitemid 27434608)
29. K. Ohara, H. Inoue, and T. Nozawa Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation Int J Cardiol 126 2008 316 321 (Pubitemid 351649385)
30. J.D. Lindh, L. Holm, and M.L. Dahl Incidence and predictors of severe bleeding during warfarin treatment J Thromb Thrombolysis 25 2008 151 159 (Pubitemid 351583663)
31. V.E. Hagens, K.M. Vermeulen, and E.M. TenVergert Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation - results from the RAte Control versus Electrical cardioversion (RACE) study Eur Heart J 25 2004 1542 1549 (Pubitemid 39165633)
32. D.A. Marshall, A.R. Levy, and H. Vidaillet Cost-effectiveness of rhythm versus rate control in atrial fibrillation Ann Intern Med 141 2004 653 661 (Pubitemid 39440011)
33. A. Pietrasik, D.A. Kosior, and M. Niewada The cost comparison of rhythm and rate control strategies in persistent atrial fibrillation Int J Cardiol 118 2007 21 27 (Pubitemid 46517682)
34. R.G. Hart, L.A. Pearce, and V.T. Miller Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies Cerebrovasc Dis 10 2000 39 43 (Pubitemid 30034856)
35. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC) Eur Heart J 31 2010 2369 2429
36. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology/American Heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354